Genmab Total Long-Term Assets 2019-2024 | GMAB

Genmab total long-term assets for the quarter ending September 30, 2024 were $2.353B, a 628.81% increase year-over-year.

  • Genmab total long-term assets for 2023 were $0.312B, a 15.97% increase from 2022.
  • Genmab total long-term assets for 2022 were $0.269B, a 10.53% decline from 2021.
  • Genmab total long-term assets for 2021 were $0.301B, a 16.5% decline from 2020.

Genmab Total Long-Term Assets 2019-2024 | GMAB

  • Genmab total long-term assets for 2023 were $0.312B, a 15.97% increase from 2022.
  • Genmab total long-term assets for 2022 were $0.269B, a 10.53% decline from 2021.
  • Genmab total long-term assets for 2021 were $0.301B, a 16.5% decline from 2020.